Rapid quantitative analysis of oxiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry

被引:14
作者
Son, J
Lee, J
Lee, M
Lee, E
Lee, KT
La, S
Kim, DH
机构
[1] Korea Adv Inst Sci & Technol, Bioanal & Biotransformat Res Ctr, Seoul 130650, South Korea
[2] Kyunghee Univ, Coll Pharm, Seoul, South Korea
关键词
oxiracetam; pharmacokinetics; LC-MS/MS; multiple reaction monitoring;
D O I
10.1016/j.jpba.2004.05.010
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid and accurate reversed-phase liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed and validated for the quantitative determination of oxiracetam in human plasma. After addition of internal standard (piracetam) plasma was precipitated with two volumes of acetonitrile and the supernatant was evaporated. The residues were dissolved in 0.1% acetic acid and analyzed by reversed-phase HPLC with the detection of the analyte in the multiple reaction monitoring (MRM) mode. This method for the determination of oxiracetam was accurate and reproducible, with a limit of quantitation of 0.2 mug/ml in human plasma. The standard calibration curve for oxiracetam was linear (r(2) = 0.999) over the concentration range 0.2-40.0 mug/ml in human plasma. The intra- and inter-day precision over the concentration range of oxiracetam was lower than 8.3% (relative standard deviation, %R.S.D.), and accuracy was between 92.5-106.4%. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 8 条
[1]  
BANFI S, 1986, CLIN NEUROPHARMACOL, V9, pS19, DOI 10.1097/00002826-198609003-00005
[2]   DETERMINATION OF OXIRACETAM IN PLASMA AND URINE BY COLUMN-SWITCHING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
LECAILLON, JB ;
SOUPPART, C ;
LEDUIGOU, F ;
DUBOIS, JP .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1989, 497 :223-230
[3]   Simultaneous quantitation of enalapril and enalaprilat in human plasma by 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry [J].
Lee, J ;
Son, J ;
Lee, M ;
Lee, KT ;
Kim, DH .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2003, 17 (11) :1157-1162
[4]  
PIFFERI G, 1977, FARMACO-ED SCI, V32, P602
[5]   DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL, PSYCHOMETRIC AND NEUROPHYSIOLOGICAL INVESTIGATIONS WITH OXIRACETAM IN THE ORGANIC BRAIN-SYNDROME OF LATE LIFE [J].
SALETU, B ;
LINZMAYER, L ;
GRUNBERGER, J ;
PIETSCHMANN, H .
NEUROPSYCHOBIOLOGY, 1985, 13 (1-2) :44-52
[6]   DETERMINATION OF OXIRACETAM IN HUMAN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION [J].
SIMPSON, RC ;
BOPPANA, VK ;
HWANG, BYH ;
RHODES, GR .
JOURNAL OF CHROMATOGRAPHY, 1993, 631 (1-2) :227-232
[7]   OXIRACETAM PREVENTS ELECTROSHOCK-INDUCED DECREASE IN BRAIN ACETYLCHOLINE AND AMNESIA [J].
SPIGNOLI, G ;
PEPEU, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 126 (03) :253-257
[8]   DETERMINATION OF OXIRACETAM IN HUMAN-SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
VISCONTI, M ;
SPALLUTO, R ;
CROLLA, T ;
PIFFERI, G ;
PINZA, M .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 416 (02) :433-438